Risperidone: all 265 studies that test it
Page 1 of 3. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- Risperidone vs Cariprazine in Acute ManiaNot yet recruitingNCT07665073Phase 4
- Study to Evaluate Efficacy and Safety of Roluperidone in Adult Subjects With Negative Symptoms and Stable Positive Symptoms of Schizophrenia and to Evaluate the Relapse Rate of Roluperidone and Antipsychotic MedicationsRecruitingNCT07565428Phase 3
- Cerebellum-based Imaging Neural Markers for Antipsychotic ResponseRecruitingNCT07483294Phase 4
- Biomarkers to Enhance Early Schizophrenia TreatmentRecruitingNCT06969755Phase 4
- Subjective Experience Following PsilocybinRecruitingNCT06768944Phase 2
- Imaging the Effects of Serotonin 2A Receptor Modulation on Synaptic Density in Treatment-resistant Depression (SYNVEST)RecruitingNCT06512220Phase 2
- Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms.RecruitingNCT06482554Phase 3
- EFFECT OF RISPERIDONE vs ARIPIPRAZOLE ON OXIDATIVE STRESS IN PATIENTS WITH AUTISM SPECTRUM DISORDER: A RANDOMIZED CONTROLLED TRIALNot yet recruitingNCT05868720Not applicable
- "Extended" (Alternate Day) Antipsychotic DosingRecruitingNCT04478838Phase 4
- The Psychiatric and Cognitive Phenotypes in Velocardiofacial SyndromeRecruitingNCT00768820Phase 4
- Safety, Tolerability, and Pharmacokinetics of Switching From Oral Risperidone to Risperidone ImplantCompletedNCT04418466Phase 1/2Results posted
- Risperidone for the Treatment of Huntington's Disease Involuntary MovementsCompletedNCT04201834Phase 2Results posted
- Safety, Tolerability, Pharmacokinetics and Efficacy of 180 mg Subcutaneous Risperidone From 6 mg Oral RisperidoneCompletedNCT03978832Phase 4Results posted
- A Study to Test if TV-46000 is Safe for Maintenance Treatment of SchizophreniaCompletedNCT03893825Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label ExtensionCompletedNCT03870880Phase 3Results posted
- A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical AntipsychoticCompletedNCT03568500Phase 4Results posted
- Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With SchizophreniaCompletedNCT03503318Phase 3Results posted
- Biomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaCompletedNCT03323437Phase 4Results posted
- Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant SchizophreniaTerminatedNCT03230864Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Risperidone in Situ Microparticle (ISM)® in Patients With Acute SchizophreniaCompletedNCT03160521Phase 3Results posted
- Cost- Effectiveness and Quality of Life Assessment in Bipolar Disorder Depressive EpisodeCompletedNCT02918097Phase 4Results posted
- Safety and Tolerability of Risperidone ImplantsCompletedNCT02773576Phase 3Results posted
- Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaCompletedNCT02717195Phase 3Results posted
- Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane ImplantCompletedNCT02658357Phase 2Results posted
- A Study to Assess the Clinical Utility of Antipsychotic Medication Levels in Plasma as Determined by Liquid Chromatography-Tandem Mass SpectrometryTerminatedNCT02462473Phase 2Results posted
- Acute D2 Receptor Blockade Induced Neuronal Network Changes in Human VolunteersCompletedNCT01931059Not applicableResults posted
- An Efficacy and Safety Study of Risperidone Long-Acting Microspheres in Participants With Schizophrenia, Schizophreniform or Schizoaffective DisordersCompletedNCT01855074Phase 4Results posted
- Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/EfficacyCompletedNCT01677377Phase 2Results posted
- Risperidone and Desipramine in Alcohol Use and SchizophreniaCompletedNCT01411085Phase 2Results posted
- Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)CompletedNCT01333072Phase 4Results posted
- Different Safety Profile of Risperidone and Paliperidone Extended-releaseCompletedNCT01284959Phase 4Results posted
- A Study to Evaluate the Safety and the Effects of Risperidone Compared With Other Atypical Antipsychotic Drugs on the Growth and Sexual Maturation in ChildrenCompletedNCT01050582Phase 4Results posted
- An Efficacy and Safety Study of Long Acting Injectable Risperidone and Oral Risperidone in Participants With Schizophrenia or Schizoaffective DisorderCompletedNCT00992407Phase 4Results posted
- A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsTerminatedNCT00934635Phase 4Results posted
- Treatment of Severe Childhood Aggression (The TOSCA Study)CompletedNCT00796302Phase 4Results posted
- Side Effect Study of Antipsychotic Medicines to Treat Childhood Bipolar DisorderTerminatedNCT00746252Not applicableResults posted
- Actigraphic Analysis of Treatment ResponseCompletedNCT00723580Not applicableResults posted
- Best Event Schizophrenia Trial--A Randomized Double-Blind Trial of Aripiprazole and Risperidone in SchizophreniaTerminatedNCT00712270Phase 4Results posted
- A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male VolunteersCompletedNCT00698022Phase 1Results posted
- Pharmacogenomics in Autism TreatmentCompletedNCT00584701Phase 2/3Results posted
- Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?CompletedNCT00571688Phase 4Results posted
- Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to PaliperidoneCompletedNCT00535132Phase 4Results posted
- Glucose and Lipid Metabolism on Antipsychotic MedicationCompletedNCT00515723Not applicableResults posted
- Metabolic Signatures and Biomarkers in SchizophreniaCompletedNCT00466310Phase 1Results posted
- Antipsychotic Discontinuation in Alzheimer's DiseaseCompletedNCT00417482Phase 4Results posted
- Risperidone or Cognitive-Behavioral Therapy for Improving Medication Treatment for Obsessive-compulsive DisorderCompletedNCT00389493Not applicableResults posted
- Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine DependenceCompletedNCT00385801Phase 2Results posted
- Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset SchizophreniaCompletedNCT00333177Phase 4Results posted
- Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating EfficacyCompletedNCT00330863Phase 4Results posted
- Oral Versus Injectable Risperidone for Treating First-Episode SchizophreniaCompletedNCT00330551Phase 4Results posted
- Comparison of Aripiprazole and Risperidone for the Treatment of People With First-Episode PsychosisCompletedNCT00320671Phase 4Results posted
- Placebo Controlled Trial of Valproate and Risperidone in Young Children With Bipolar DisordersCompletedNCT00221403Phase 3Results posted
- Metabolic Effects of Antipsychotics in ChildrenCompletedNCT00205699Phase 4Results posted
- Supported Employment and Skills Training in Conjunction With Pharmacotherapy in Schizophrenia PatientsCompletedNCT00183625Phase 4Results posted
- Risperidone and Divalproex Sodium With MRI Assessment in Pediatric BipolarCompletedNCT00176202Phase 3Results posted
- A Double-blind, Placebo Controlled Trial of Risperidone for the Treatment of Anorexia NervosaCompletedNCT00140426Phase 4Results posted
- A Study of the Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood EpisodesCompletedNCT00132678Phase 3Results posted
- Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use DisorderCompletedNCT00130923Phase 4Results posted
- Risperidone Treatment for Military Service Related Chronic Post Traumatic Stress DisorderCompletedNCT00099983Phase 2Results posted
- Study of Outcome and Safety of Lithium, Divalproex and Risperidone for Mania in Children and AdolescentsCompletedNCT00057681Phase 3Results posted
- Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking ClozapineCompletedNCT00056498Phase 4Results posted
- Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)CompletedNCT00053703Phase 4Results posted
- Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
- A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective DisorderWithdrawnNCT06878833Phase 3
- KF2022#3-trial: Effect of Tea and Cola Beverage on Absorption of Risperidone Oral SolutionCompletedNCT06218979Phase 1
- Synergistic Effect of Vitamin E & D in Reducing Risk of Effects Associated With Atypical Anti-psychoticsCompletedNCT06200584Not applicable
- Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast CancerTerminatedNCT06161792Phase 2
- Study to Evaluate the Pharmacokinetics (PK) and Safety/Tolerability of Long-Acting Oral LYN-005CompletedNCT05779241Phase 3
- Does Psilocybin Require Psychedelic Effects to Treat Depression?CompletedNCT05710237Phase 2
- Electrical Brain Stimulation and Pharmacological Treatments in Autism Spectrum DisorderCompletedNCT05491720Phase 1
- Comparative Bioavailability of Risperidone.CompletedNCT05179525Phase 1
- A Study to Assess the Treatment of Schizophrenia With Paliperidone Palmitate in Rwandan Healthcare SettingsCompletedNCT04940039Phase 4
- Neuroprotective Effects of Risperdal on Brain and Cognition in 22q11 Deletion SyndromeTerminatedNCT04639960Not applicable
- Reducing the Abuse Liability of Prescription OpioidsCompletedNCT04587115Early Phase 1
- Atypical Antipsychotics Influence on the Safety of the Heart and Monitoring Indicators Model BuildingStatus unknownNCT04446234Phase 4
- Therapeutic Issues for AutismCompletedNCT03887754Phase 2
- Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-upStatus unknownNCT03883204Phase 4
- Reducing the Abuse of Opioids in Drug UsersTerminatedNCT03837860Early Phase 1
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical AntipsychoticsCompletedNCT03730857Phase 1
- A Study to Evaluate the Ability of Conducting a Study of Oral Risperidone Followed by Paliperidone Palmitate in Rwandan Healthcare FacilitiesCompletedNCT03713658Phase 4
- Comparative Bioavailability of RisperidoneCompletedNCT03527186Phase 1
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
- Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?TerminatedNCT03227562Phase 3
- Bioequivalence Study of Xian Risperdal Tablets Compared With Gurabo Risperdal Tablets Under Fasting and Fed Conditions in Chinese Healthy ParticipantsWithdrawnNCT03220867Phase 1
- A Study of Diagnosis and Treatment of Depression Based on Biological Evidence of Dopamine Reward PathwayStatus unknownNCT03148509Phase 4
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upStatus unknownNCT03090503Phase 4
- Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With SchizophreniaCompletedNCT03075657Phase 4
- The Optimal Treatment for Treatment-resistant SchizophreniaStatus unknownNCT02926976Not applicable
- Comparison of the Effectiveness of Brexpiprazole With That of RisperidoneWithdrawnNCT02758067Phase 3
- Transcranial Direct Current Stimulation for Hallucinations in First-Episode SchizophreniaWithdrawnNCT02661347Not applicable
- The Role of miR-30 Family Dysregulation in Response to Antipsychotic TreatmentStatus unknownNCT02650102Phase 1/2
- Whole Blood and Plasma Sample Collection for the Development of Antipsychotic Immunoassays From Participants Taking Aripiprazole, Olanzapine, Paliperidone, or RisperidoneCompletedNCT02634463Phase 1
- Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in GhanaCompletedNCT02593734Phase 4
- Nicotinic Receptors and SchizophreniaWithdrawnNCT02538081Phase 1/2
- Schizotypal Personality Disorder RisperidoneCompletedNCT02535156Phase 1/2
- Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upStatus unknownNCT02532491Phase 4
- Controlled Trial of Valproate Versus Risperidone in Young Children With Bipolar DisorderCompletedNCT02456454Phase 3
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedNCT02374567Phase 3
- Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4